Evidence map›Paper›PMID 41045215›Full record

ArticleJournal of chemical theory and computation2025

Structure and Dynamics of the Misfolding Intermediate in the Pathogenic T183A Prion Protein Mutant.

Carmen Biancaniello, Alessandro Emendato, Alfonso De Simone

Abstract read
In one paragraph

Article in Journal of chemical theory and computation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carmen BiancanielloDepartment of Pharmacy, University of Naples Federico II, Via D. Montesano 49, Naples 80131, Italy.
Alessandro EmendatoDepartment of Pharmacy, University of Naples Federico II, Via D. Montesano 49, Naples 80131, Italy.
Alfonso De SimoneDepartment of Pharmacy, University of Naples Federico II, Via D. Montesano 49, Naples 80131, Italy.ORCID 0000-0001-8789-9546

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Characterizing high-energy conformations in protein molecules is crucial to delineate the nature of dynamic processes that underlie biological activity, as these elusive species often play critical roles in fundamental mechanisms of the cell, such as enzyme catalysis or protein folding and aggregation, among many others. In this context, the integration of molecular simulations with experimental biophysics represents a powerful strategy to delineate complex conformational landscapes, enabling the study of transient conformations at atomic resolution. Here, we characterized intermediate states along the misfolding pathway of the human prion protein (PrP) variant T183A, which is associated with familial Creutzfeldt-Jakob disease. Using replica-averaged molecular dynamics simulations, restrained with nuclear magnetic resonance chemical shifts, we obtained structural ensembles showing enhanced conformational heterogeneity for the T183A variant compared with the WT protein. The mutant ensemble was found to populate partially misfolded states characterized by disruption of the β-sheet and local unfolding of key helical regions of the protein. Additionally, dynamic cross-correlation analyses evidenced significant loss of cooperative fluctuations across secondary structure elements, delineating how structural destabilization in the T183A variant leads to the insurgence of misfolding intermediates. Collectively, these findings provide critical insights into the underlying mechanisms of T183A-induced PrP misfolding and its consequent aggregation into amyloid fibrils.

Indexed as

Molecular Dynamics SimulationPrion ProteinsHumansMutationProtein FoldingPrion Proteins

Identifiers

PMID41045215
PMCPMC12529898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.